Scotland at forefront of global genomics initiative

A new collaboration in genomic medicine was, today, announced by Health Secretary Shona Robison and welcomed by Scottish Enterprise (SE).

The partnership between AstraZeneca and the Stratified Medicine Scotland Innovation Centre, which represents NHSScotland, Scottish Universities and industry partners, will offer unique opportunities to researchers using patients’ genetic information to develop innovative new treatments and target the right patients to the right medicines.

Julia Brown, Senior Director, Life and Chemical Sciences at SE said:

“Scottish Enterprise is delighted to participate in this collaboration between Astra Zeneca and Stratified Medicine Scotland, helping the interface between academics, clinicians and industry and in doing so accelerating the translation of innovative projects with real clinical and commercial potential.

“SE acknowledges the growing importance of Precision Medicine in modern day healthcare and this significant partnership with Astra Zeneca exemplifies industry’s recognition of the capabilities and expertise in Scotland and the ability of the Ecosystem model to bring together multiple contributors and efficiently co-ordinate cutting edge projects.”

NOTES TO EDITORS

See the Scottish Government's news release in full: http://news.scotland.gov.uk/News/Investing-in-research-2dba.aspx 

For more information on AstraZeneca visit www.astrazeneca.com 

For more information on the Stratified Medicine Scotland Innovation Centre (SMS-IC) visit http://www.stratmed.co.uk/ 

For more information on the Precision Medicine Ecosystem for Scotland (PME) visit http://news.scotland.gov.uk/News/Investing-in-the-healthcare-of-the-future-2255.aspx